Food and Drug Administration Revitalization Act
The Food and Drug Administration Revitalization Act was introduced by the 101st Congress of the United States. Senator Orrin G. Hatch was the chairperson sponsor of the federal revitalization amendment for the Food and Drug Administration.
Long title | An Act to amend the Federal Food, Drug, and Cosmetic Act to revitalize the Food and Drug Administration, and for other purposes. |
---|---|
Nicknames | Food and Drug Administration Revitalization Act of 1990 |
Enacted by | the 101st United States Congress |
Effective | November 28, 1990 |
Citations | |
Public law | 101-635 |
Statutes at Large | 104 Stat. 4583 |
Codification | |
Acts amended | Federal Food, Drug, and Cosmetic Act |
Titles amended | 21 U.S.C.: Food and Drugs |
U.S.C. sections amended |
|
Legislative history | |
|
The FDA revitalization was orchestrated by Commissioner of Food and Drugs Dr. David Kessler in pursuant of the congressional authorization permissible by 101st Senate bill 845;
☆ Digital transformation and Information technology harmonizing FDA as information agency |
☆ Enforcement programs streamlined by contingencies of FDA field activities |
☆ Establishment of Office of Criminal Investigations |
☆ New drug approval process funding by prescription drug user fee |
☆ Progressive domestic and imports investigation programs by FDA |
☆ Quality standards for mammography facilities endorsed by Mammography Quality Act |
☆ Reduction in application review times for public healthcare products |
☆ Safety information and adverse event reporting program ― MedWatch |
☆ Standardization of nutrition facts label as authorized by Nutrition Labeling Act |
The Title 21 amendment was signed into law on November 28, 1990, by the 43rd President of the United States George H. W. Bush.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.